Tapewire

Nasdaq · USD

KYTX

Kyverna Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5452
SEC CIK
0001994702
Parsed reports
68

Last 12 months

Inside the activity.

2 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202521
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 27, 2026 Filed May 29, 2026 20:30 UTC
Aktar MertDirector
GrantStock Option (right to buy) · Derivative 20,582 $0.00 Strike: $8.59 $0.00
Disclosure

SEC source: 0001193125-26-248425 · ownership.xml · derivative · entry 2

Aktar Mert · CIK 0002040256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,582

Underlying: Common Stock · 20,582 shares

Expires 2036-05-27

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC
Aktar MertDirector
GrantCommon Stock 5,093 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-248425 · ownership.xml · nonDerivative · entry 1

Aktar Mert · CIK 0002040256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,727

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC GrantStock Option (right to buy) · Derivative 20,582 $0.00 Strike: $8.59 $0.00
Disclosure

SEC source: 0001193125-26-248429 · ownership.xml · derivative · entry 4

SEIDENBERG BETH C · CIK 0001184592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,582

Underlying: Common Stock · 20,582 shares

Expires 2036-05-27

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC GrantCommon Stock 5,093 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-248429 · ownership.xml · nonDerivative · entry 1

SEIDENBERG BETH C · CIK 0001184592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,727

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC
CLARK IAN TDirector
GrantStock Option (right to buy) · Derivative 20,582 $0.00 Strike: $8.59 $0.00
Disclosure

SEC source: 0001193125-26-248435 · ownership.xml · derivative · entry 2

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,582

Underlying: Common Stock · 20,582 shares

Expires 2036-05-27

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC
CLARK IAN TDirector
GrantCommon Stock 5,093 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-248435 · ownership.xml · nonDerivative · entry 1

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,727

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC
Cohen Fred EDirector
GrantStock Option (right to buy) · Derivative 20,582 $0.00 Strike: $8.59 $0.00
Disclosure

SEC source: 0001193125-26-248434 · ownership.xml · derivative · entry 3

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,582

Underlying: Common Stock · 20,582 shares

Expires 2036-05-27

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC
Cohen Fred EDirector
GrantCommon Stock 5,093 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-248434 · ownership.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,727

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:30 UTC
Shaw ChristiDirector · Executive Chairperson
Tax withholdingCommon Stock 4,194 $8.59 $36,026.46
Disclosure

SEC source: 0001193125-26-248427 · ownership.xml · nonDerivative · entry 1

Shaw Christi · CIK 0001702473 · Director · Executive Chairperson

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,741

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on May 27, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock unit award for 16,634 shares that vested in full on May 27, 2026.

Read SEC document
May 18, 2026 Filed May 20, 2026 20:30 UTC
Martini Gregory S.Chief Financial Officer
GrantStock Option (right to buy) · Derivative 325,000 $0.00 Strike: $8.54 $0.00
Disclosure

SEC source: 0001193125-26-232681 · ownership.xml · derivative · entry 1

Martini Gregory S. · CIK 0002053936 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,000

Underlying: Common Stock · 325,000 shares

Expires 2036-05-18

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on May 18, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:30 UTC
Dac NadiaChief Commercial Officer
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001193125-26-209120 · ownership.xml · derivative · entry 1

Dac Nadia · CIK 0001773151 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-05-04

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on May 4, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
GEHCHAN NAJISee Remarks
GrantStock Option (right to buy) · Derivative 105,000 $0.00 Strike: $8.95 $0.00
Disclosure

SEC source: 0001193125-26-110941 · ownership.xml · derivative · entry 2

GEHCHAN NAJI · CIK 0002052410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2036-03-13

F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
GEHCHAN NAJISee Remarks
GrantCommon Stock 18,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-110941 · ownership.xml · nonDerivative · entry 1

GEHCHAN NAJI · CIK 0002052410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

F1 · shares: Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
Biddle Warner WestonDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 350,000 $0.00 Strike: $8.95 $0.00
Disclosure

SEC source: 0001193125-26-110920 · ownership.xml · derivative · entry 2

Biddle Warner Weston · CIK 0002034523 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2036-03-13

F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
Biddle Warner WestonDirector · Chief Executive Officer
GrantCommon Stock 58,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-110920 · ownership.xml · nonDerivative · entry 1

Biddle Warner Weston · CIK 0002034523 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,000

F1 · shares: Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
GRASSO MARCChief Financial Officer
GrantStock Option (right to buy) · Derivative 65,000 $0.00 Strike: $8.95 $0.00
Disclosure

SEC source: 0001193125-26-110934 · ownership.xml · derivative · entry 2

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2036-03-13

F2 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
March 13, 2026 Filed Mar 17, 2026 16:30 UTC
GRASSO MARCChief Financial Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-110934 · ownership.xml · nonDerivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:30 UTC GrantStock Option (right to buy) · Derivative 42,945 $0.00 Strike: $7.95 $0.00
Disclosure

SEC source: 0001193125-26-076897 · ownership.xml · derivative · entry 2

Emany Sravan Kumar · CIK 0001897662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,945

Underlying: Common Stock · 42,945 shares

Expires 2036-02-24

F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:30 UTC GrantCommon Stock 11,006 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-076897 · ownership.xml · nonDerivative · entry 1

Emany Sravan Kumar · CIK 0001897662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,006

F1 · shares: Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 24, 2026 Filed Mar 4, 2026 21:30 UTC GrantStock Option (right to buy) · Derivative 42,945 $0.00 Strike: $7.95 $0.00
Disclosure

SEC source: 0001193125-26-091626 · ownership.xml · derivative · entry 2

Miller Andrew Craig · CIK 0001777760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,945

Underlying: Common Stock · 42,945 shares

Expires 2036-02-24

F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 24, 2026 Filed Mar 4, 2026 21:30 UTC GrantCommon Stock 11,006 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-091626 · ownership.xml · nonDerivative · entry 1

Miller Andrew Craig · CIK 0001777760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,006

F1 · shares: Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 09, 2026 Filed Feb 11, 2026 21:30 UTC
Pujols MayobanexChief Technology Officer
GrantStock Option (right to buy) · Derivative 300,000 $0.00 Strike: $8.08 $0.00
Disclosure

SEC source: 0001193125-26-046665 · ownership.xml · derivative · entry 1

Pujols Mayobanex · CIK 0002109086 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-02-09

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 9, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive

Read SEC document
January 12, 2026 Filed Jan 14, 2026 22:00 UTC
Shaw ChristiDirector · Executive Chairperson
GrantStock Option (right to buy) · Derivative 185,000 $0.00 Strike: $8.23 $0.00
Disclosure

SEC source: 0001193125-26-013021 · ownership.xml · derivative · entry 3

Shaw Christi · CIK 0001702473 · Director · Executive Chairperson

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 185,000 shares

Expires 2036-01-11

F3 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 12, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
January 12, 2026 Filed Jan 14, 2026 22:00 UTC
Shaw ChristiDirector · Executive Chairperson
GrantCommon Stock 24,301 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-013021 · ownership.xml · nonDerivative · entry 2

Shaw Christi · CIK 0001702473 · Director · Executive Chairperson

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,935

F2 · shares: Represents a performance restricted stock unit award of common stock, which will vest upon the Issuer's common stock achieving certain specified prices per share.

Read SEC document
January 12, 2026 Filed Jan 14, 2026 22:00 UTC
Shaw ChristiDirector · Executive Chairperson
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-013021 · ownership.xml · nonDerivative · entry 1

Shaw Christi · CIK 0001702473 · Director · Executive Chairperson

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,634

F1 · shares: Represents a restricted stock unit award of common stock, 1/4th of the shares subject to which shall vest on January 12, 2027, and 1/4th of the shares subject to the restricted stock unit award shall vest following each one-year period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
December 18, 2025 Filed Dec 22, 2025 16:42 UTC PurchaseCommon Stock 133,333 $7.50 $999,997.50
Disclosure

SEC source: 0001104659-25-123596 · tm2534053-1_4seq1.xml · nonDerivative · entry 1

Westlake BioPartners Opportunity Fund I, L.P. · CIK 0001811946 · 10% owner

Westlake BioPartners Opportunity GP I, LLC · CIK 0001811945 · 10% owner

Westlake BioPartners Fund I, L.P. · CIK 0001749591 · 10% owner

Westlake BioPartners GP I, LLC · CIK 0002007650 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 869,317

F1 · ownership.nature: Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I"). The voting and dispositive control over Westlake Opportunity GP I is held by the managing director of Westlake Opportunity GP I, Beth Seidenberg, and whom disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of such person's pecuniary interest therein, if any. Sean Harper, a Reporting Person on Westlake Opportunity's prior Section 16 filings with respect to the Issuer, is no longer a managing director of Westlake Opportunity GP I, and accordingly, is not a Reporting Person on this Form 4.

Read SEC document
December 18, 2025 Filed Dec 22, 2025 16:43 UTC PurchaseCommon Stock 133,333 $7.50 $999,997.50
Disclosure

SEC source: 0001104659-25-123597 · tm2534053-2_4seq1.xml · nonDerivative · entry 1

SEIDENBERG BETH C · CIK 0001184592 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 869,317

F1 · ownership.nature: Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I"). The Reporting Person is the managing director of Westlake Opportunity GP I and has sole voting and dispositive control over Westlake Opportunity GP I, and disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of the Reporting Person's pecuniary interest therein, if any.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 01:30 UTC
Walker Karen MarieChief Technology Officer
Exercise / conversionStock option (right to buy) · Derivative 23,998 $0.00 Strike: $4.83 $0.00
Disclosure

SEC source: 0001193125-25-323332 · ownership.xml · derivative · entry 3

Walker Karen Marie · CIK 0002008556 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,865

Underlying: Common Stock · 23,998 shares

Expires 2033-11-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.

F2 · derivative.exercise_date: 25% of the original number of shares subject to the option vested on January 1, 2025, and 1/48th of the original number of shares subject to the option vests in monthly installments thereafter, subject to the Reporting Person's continuous service.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 01:30 UTC
Walker Karen MarieChief Technology Officer
SaleCommon Stock 23,998 $12.20 $292,775.60
Disclosure

SEC source: 0001193125-25-323332 · ownership.xml · nonDerivative · entry 2

Walker Karen Marie · CIK 0002008556 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,636

F1 · kind: The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.

Read SEC document
December 15, 2025 Filed Dec 18, 2025 01:30 UTC
Walker Karen MarieChief Technology Officer
Exercise / conversionCommon Stock 23,998 $4.83 $115,910.34
Disclosure

SEC source: 0001193125-25-323332 · ownership.xml · nonDerivative · entry 1

Walker Karen Marie · CIK 0002008556 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 20:28 UTC
GRASSO MARCChief Financial Officer
GrantStock Option (right to buy) · Derivative 450,000 $0.00 Strike: $3.07 $0.00
Disclosure

SEC source: 0000950170-25-092421 · ownership.xml · derivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2035-06-30

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 30, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:32 UTC
Aktar MertDirector
GrantStock Option (right to buy) · Derivative 65,351 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0000950170-25-080451 · ownership.xml · derivative · entry 2

Aktar Mert · CIK 0002040256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,351

Underlying: Common Stock · 65,351 shares

Expires 2035-05-29

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:32 UTC
Aktar MertDirector
GrantCommon Stock 16,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-080451 · ownership.xml · nonDerivative · entry 1

Aktar Mert · CIK 0002040256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,634

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:35 UTC GrantStock Option (right to buy) · Derivative 65,351 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0000950170-25-080456 · ownership.xml · derivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,351

Underlying: Common Stock · 65,351 shares

Expires 2035-05-29

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:35 UTC GrantCommon Stock 16,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-080456 · ownership.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,634

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:35 UTC
SEIDENBERG BETH CDirector · 10% owner
GrantStock Option (right to buy) · Derivative 65,351 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0000950170-25-080457 · ownership.xml · derivative · entry 4

SEIDENBERG BETH C · CIK 0001184592 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,351

Underlying: Common Stock · 65,351 shares

Expires 2035-05-29

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:35 UTC
SEIDENBERG BETH CDirector · 10% owner
GrantCommon Stock 16,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-080457 · ownership.xml · nonDerivative · entry 1

SEIDENBERG BETH C · CIK 0001184592 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,634

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:32 UTC
CLARK IAN TDirector
GrantStock Option (right to buy) · Derivative 65,351 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0000950170-25-080450 · ownership.xml · derivative · entry 2

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,351

Underlying: Common Stock · 65,351 shares

Expires 2035-05-29

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:32 UTC
CLARK IAN TDirector
GrantCommon Stock 16,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-080450 · ownership.xml · nonDerivative · entry 1

CLARK IAN T · CIK 0001336504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,634

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:30 UTC
Cohen Fred EDirector · 10% owner
GrantStock Option (right to buy) · Derivative 65,351 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0000950170-25-080447 · ownership.xml · derivative · entry 3

Cohen Fred E · CIK 0001339358 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,351

Underlying: Common Stock · 65,351 shares

Expires 2035-05-29

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:30 UTC
Cohen Fred EDirector · 10% owner
GrantCommon Stock 16,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-080447 · ownership.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,634

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:40 UTC
Shaw ChristiDirector
GrantStock Option (right to buy) · Derivative 65,351 $0.00 Strike: $2.63 $0.00
Disclosure

SEC source: 0000950170-25-080459 · ownership.xml · derivative · entry 2

Shaw Christi · CIK 0001702473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,351

Underlying: Common Stock · 65,351 shares

Expires 2035-05-29

F2 · derivative.exercise_date: All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 22:40 UTC
Shaw ChristiDirector
GrantCommon Stock 16,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-080459 · ownership.xml · nonDerivative · entry 1

Shaw Christi · CIK 0001702473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,634

F1 · shares: Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 21:40 UTC
Walker Karen MarieChief Technology Officer
GrantCommon Stock 13,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-054342 · ownership.xml · nonDerivative · entry 1

Walker Karen Marie · CIK 0002008556 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,636

F1 · shares: Represents a restricted stock unit award of common stock, 1/4th of which shall vest on April 11, 2026, and 1/4th of which shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 17:42 UTC
Jones Ryan AlexanderChief Financial Officer
GrantCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-054344 · ownership.xml · nonDerivative · entry 1

Jones Ryan Alexander · CIK 0002007219 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,950

F1 · shares: Represents a restricted stock unit award of common stock, 1/4th of which shall vest on April 11, 2026, and 1/4th of which shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 22:55 UTC
Shaw ChristiDirector
GrantStock Option (right to buy) · Derivative 38,679 $0.00 Strike: $3.03 $0.00
Disclosure

SEC source: 0000950170-25-023428 · ownership.xml · derivative · entry 1

Shaw Christi · CIK 0001702473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,679

Underlying: Common Stock · 38,679 shares

Expires 2035-02-14

F1 · derivative.exercise_date: 100% of the shares subject to the option shall be fully vested and exercisable on October 30, 2025, subject to the Reporting Person's continuous service to the Issuer as an advisor on and through the vesting date, inclusive.

Read SEC document
January 22, 2025 Filed Jan 24, 2025 20:05 UTC
GEHCHAN NAJISee Remarks
GrantStock Option (right to buy) · Derivative 425,000 $0.00 Strike: $3.29 $0.00
Disclosure

SEC source: 0000950170-25-008961 · ownership.xml · derivative · entry 1

GEHCHAN NAJI · CIK 0002052410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,000

Underlying: Common Stock · 425,000 shares

Expires 2035-01-22

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 22, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
October 21, 2024 Filed Oct 24, 2024 10:05 UTC
Aktar MertDirector
GrantStock Option (right to buy) · Derivative 87,741 $0.00 Strike: $5.20 $0.00
Disclosure

SEC source: 0000950170-24-116840 · ownership.xml · derivative · entry 1

Aktar Mert · CIK 0002040256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,741

Underlying: Common Stock · 87,741 shares

Expires 2034-10-21

F1 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on each monthly anniversary, such that 100% of the shares subject to the option shall be fully vested and exercisable on the third anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 21:18 UTC
Biddle Warner WestonDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 2,579,259 $0.00 Strike: $6.89 $0.00
Disclosure

SEC source: 0000950170-24-107968 · ownership.xml · derivative · entry 1

Biddle Warner Weston · CIK 0002034523 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,579,259

Underlying: Common Stock · 2,579,259 shares

Expires 2034-09-16

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on September 16, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
September 16, 2024 Filed Sep 19, 2024 01:16 UTC
Shaw ChristiDirector
GrantStock Option (right to buy) · Derivative 66,592 $0.00 Strike: $6.89 $0.00
Disclosure

SEC source: 0000950170-24-107967 · ownership.xml · derivative · entry 1

Shaw Christi · CIK 0001702473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,592

Underlying: Common Stock · 66,592 shares

Expires 2034-09-16

F1 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on each monthly anniversary, such that 100% of the shares subject to the option shall be fully vested and exercisable on the third anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.